USPTO serial 99497202
HELIX WAYFINDER
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, CATHERINE ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HELIX WAYFINDER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Mateo, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DEVIN LEE JOSEPH LOOIJEN
400 S El Camino RealSTE 300San Mateo, CA 94402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SAAS) services featuring software providing access to reports facilitated by using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable cloud computing software for accessing reports indicating clinical interpretation of genetic variants; Providing temporary use of online non-downloadable cloud computing software providing access to reports facilitated by using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable cloud computing software providing access to reports facilitated by using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics | ACTIVE | Jul 8, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 23, 2026 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Oct 23, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 22, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 22, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 22, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 8, 2026 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 8, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Sep 16, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 16, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 16, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 16, 2026 | IUAA | USE AMENDMENT ACCEPTED | — |
| Sep 11, 2026 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Sep 11, 2026 | IUAF | USE AMENDMENT FILED | — |
| Sep 11, 2026 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Sep 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 23, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 23, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Mar 31, 2026 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 31, 2026 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 31, 2026 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Mar 31, 2026 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Mar 24, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 14, 2025 | NWAP | NEW APPLICATION ENTERED | — |